Aria Jafari
Assistant Professor, Rhinology, Sinus and Endoscopic Skull Base Surgery
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (4)
Background The present study explores the effect of sociodemographics and comorbidities on the calculated minimal clinically important difference (MCID) for 22‐item Sinonasal Outcome Test (SNOT‐22) scores in patients with medically treated chronic rhinosinusitis (CRS). The importance of delineating a threshold to indicate clinically meaningful changes perceived by a patient is well acknowledged, yet the influence of patient‐specific factors on MCID has not been fully elucidated. Methods Patients with CRS ( n = 221) presenting to a tertiary care practice reported their change in disease burden with anchor questions following CRS‐directed medical treatment. Baseline sociodemographics, pertinent history, and comorbid conditions, as well as pre‐ and post‐treatment SNOT‐22 scores were also collected. Adjusted logistic regression was utilized to determine the factors influencing MCID. Results Among the 221 patients, 43.9% ( n = 97) reported improvement following medical treatment. Gender, education level, depression, and migraine were identified as significant factors influencing perceived improvement. Our predictive model, incorporating these variables, achieved an area under the receiver operating characteristic curve of 0.818 (95% confidence interval [CI] = 0.762, 0.875), with a sensitivity of 74.4% and specificity of 77.9%. Changes in SNOT‐22 scores were not strongly associated with perceived improvement in patients with depression (odds ratio [OR] = 1.06; 95% CI = 0.98, 1.14; p = 0.140). Conversely, patients with migraines perceived more pronounced improvements or deteriorations at the extremes of SNOT‐22 score changes (OR = 0.84; 95% CI = 0.76, 0.93; p = 0.001). Conclusion Our findings underscore the substantial impact of patient‐specific sociodemographics and comorbidities on the calculation of MCID values for the SNOT‐22. This study advances our understanding of variability in MCID and demonstrates the complex milieu of factors affecting patients’ perceived clinical outcomes.
Year:
2025
Background Patients with chronic rhinosinusitis (CRS) can experience cognitive dysfunction. The literature on this topic mostly reflects patient‐reported measurements. Our goal was to assess cognitive function in patients with CRS using objective measures, including saccadic eye movements—a behavioral response reflecting cognitive and sensory information integration that is often compromised in conditions with impaired cognition. Methods Participants (N = 24 with CRS, N = 23 non‐CRS healthy controls) enrolled from rhinology clinic underwent sinonasal evaluation, quality of life assessment (Sino‐nasal Outcome Test 22 [SNOT‐22]), and cognitive assessment with the Neuro‐QOL Cognitive Function‐Short Form, the Montreal Cognitive Assessment (MoCA), and recording of eye movements using video‐oculography. Results Participants with CRS were more likely to report cognitive dysfunction (Neuro‐QOL; 45.8% vs. 8.7%; p = 0.005) and demonstrate mild or greater cognitive impairment (MoCA; 41.7% vs. 8.7%; p = 0.005) than controls. Additionally, participants with CRS performed worse on the MoCA overall and within the executive functioning and memory domains (all p < 0.05) and on the anti‐saccade ( p = 0.014) and delay saccade ( p = 0.044) eye movement tasks. Poorer performance on the MoCA ( r = −0.422; p = 0.003) and the anti‐saccade ( r = −0.347; p = 0.017) and delay saccade ( r = −0.419; p = 0.004) eye movement tasks correlated with worse CRS severity according to SNOT‐22 scores. Conclusion This study is the first to utilize objective eye movement assessments in addition to researcher‐administered cognitive testing in patients with CRS. These patients demonstrated a high prevalence of cognitive dysfunction, most notably within executive functioning and memory domains, with the degree of dysfunction correlating with the severity of CRS.
Year:
2024
Introduction The bowing index (BI) and normalized glottal gap area (NGGA) are used to quantify vocal fold morphology in ARVA; however, the influence of the distance between the flexible laryngoscope lens and the target area is not known. The goal is to test whether the endoscopic distance impacts vocal fold morphology measurements in patients with ARVA during flexible video laryngostroboscopy (VLS). Method Patients with ARVA who underwent VLS were included. Images were classified into near (close to the petiole of the epiglottis) and far (below nasopharynx, with tongue base and entire epiglottis visible) conditions. BI was calculated using a mobile application, and NGGA was measured using ImageJ. Results This study included 23 patients; the mean age was 77 ± 7 years. Mean BI measured at the near distance was higher than far distances with a mean difference of 1.94 (95% CI: 0.92–2.96, p = 0.001). NGGA showed difference with changed distance −0.24 (95% CI: −0.48 to 0.01, p < 0.05).When stratifying patients into two groups based on median BI measurement, there was a statistically significant difference between near and far conditions, with increased BI in the near condition for patients above the median ( p < 0.05), but no difference between the near and far condition for patients with BI below the median. Conclusion The BI and NGGA were impacted by the endoscopic distance during flexible VLS. BI was significantly higher in the near condition compared with the far condition. The difference in BI between the near and far conditions was more pronounced when the vocal fold bowing was greater. These findings call for heightened awareness of measurement discrepancies secondary to the endoscopic distance during flexible laryngostroboscopy. Level of Evidence 2 Laryngoscope , 134:4649–4655, 2024
Year:
2024
Background Patients with sinonasal malignancy (SNM) present with significant sinonasal quality of life (QOL) impairment. Global sinonasal QOL as measured by the 22‐item Sinonasal Outcomes Test (SNOT‐22) has been shown to improve with treatment. This study aims to characterize SNOT‐22 subdomain outcomes in SNM. Methods Patients diagnosed with SNM were prospectively enrolled in a multi‐center patient registry. SNOT‐22 scores were collected at the time of diagnosis and through the post‐treatment period for up to 5 years. Multivariable regression analysis was used to identify drivers of variation in SNOT‐22 subdomains. Results Note that 234 patients were reviewed, with a mean follow‐up of 22 months (3 months–64 months). Rhinologic, psychological, and sleep subdomains significantly improved versus baseline (all p < 0.05). Subanalysis of 40 patients with follow‐up at all timepoints showed statistically significant improvement in rhinologic, extra‐nasal, psychological, and sleep subdomains, with minimal clinically important difference met between 2 and 5 years in sleep and psychological subdomains. Adjuvant chemoradiation was associated with worse outcomes in rhinologic (adjusted odds ratio (5.22 [1.69–8.66])), extra‐nasal (2.21 [0.22–4.17]) and ear/facial (5.53 [2.10–8.91]) subdomains. Pterygopalatine fossa involvement was associated with worse outcomes in rhinologic (3.22 [0.54–5.93]) and ear/facial (2.97 [0.32–5.65]) subdomains. Positive margins (5.74 [2.17–9.29]) and surgical approach—combined versus endoscopic (3.41 [0.78–6.05])—were associated with worse psychological outcomes. Adjuvant radiation (2.28 [0.18–4.40]) was associated with worse sleep outcomes. Conclusions Sinonasal QOL improvements associated with treatment of SNM are driven by rhinologic, extra‐nasal, psychological, and sleep subdomains.
Year:
2024
Collaborators (9)
Peter H. Hwang
-
Zara M. Patel
-
Timothy L. Smith
-
Edward C. Kuan
University of California, Irvine
Carl Snyderman
Professor
University of Pittsburgh
Eric W. Wang
University of Pittsburgh
Daniel M. Beswick
-
Neel Bhatt
University of Washington
Jayakar V. Nayak
Stanford University
Make your next move.
Prepare your application
Review drafts before you send them.